CD58 acts as a tumor promotor in hepatocellular carcinoma via activating the AKT/GSK-3β/β-catenin pathwayChuanzheng Wang(Zhongshan Hospital of Xiamen University), Xiaomin Wang(Xiamen University)Journal of Translational MedicineAugust 12, 202310.1186/s12967-023-04364-4Cited by 25SaveCiteExport RISWatch citationsRelated PapersEnoyl-coenzyme A hydratase short chain 1 silencing attenuates the proliferation of hepatocellular carcinoma by inhibiting epidermal growth factor signaling in vitro and in vivo|Molecular Medicine Reports|2012|11